Results 41 to 50 of about 94,803 (309)
Objective Existing patient‐reported outcome (PRO) measures for systemic sclerosis (SSc) have important limitations, including inadequate coverage of early disease and limited inclusion of diffuse cutaneous (dcSSc) and limited cutaneous (lcSSc) subtypes.
George J. Greene +5 more
wiley +1 more source
Measuring quality of life in clinical research – Part 3
Health-related quality of life (HRQoL) is an important outcome in cancer research, as it captures the impact of disease and treatment on patients’ daily functioning and well-being. Building on earlier discussions of HRQOL concepts and measurement methods,
Dagmara Kuliś +3 more
doaj +1 more source
Sheka Shemsi Seid,1 José Amendoeira,2 Maria Regina Ferreira2 1School of Nursing, Faculty of Health Sciences, Institute of Health, Jimma University, Jimma, Ethiopia; 2Department of Nursing, Polytechnic Institute of Santarem, Quality of life Research ...
Seid SS, Amendoeira J, Ferreira MR
doaj
ABSTRACT Background Long‐term management strategies for severe chronic rhinosinusitis with nasal polyps (CRSwNP) increasingly include biologic therapy targeting Type 2 inflammation. However, data on outcomes after complete discontinuation of dupilumab following sustained disease control are scarce.
Patrick Huber +7 more
wiley +1 more source
Determinants of HRQoL: Multivariate analysis.
Determinants of HRQoL: Multivariate analysis.
Michaël Schwarzinger (193760) +9 more
core +1 more source
Changes in self-reported and parent-reported health-related quality of life in overweight children and adolescents participating in an outpatient training: findings from a 12-month follow-up study [PDF]
Finne E, Reinehr T, Schaefer A, Winkel K, Kolip P. Changes in self-reported and parent-reported health-related quality of life in overweight children and adolescents participating in an outpatient training: findings from a 12-month follow-up study ...
Emily Finne +14 more
core +1 more source
ABSTRACT Background Olfactory dysfunction (OD) is an increasingly recognized but under‐investigated comorbidity of cystic fibrosis (CF). Its prevalence, assessment methods, and response to CF‐directed treatment, including highly effective modulator therapy (HEMT) remains incompletely characterized.
Luca Cox +5 more
wiley +1 more source
Measuring quality of life in clinical research - Part 2
This article deals with the various aspects of health-related quality of life (QoL) assessments, building upon a previous discussion of the concept and its measurement types. Specifically, the article will delve into number and timing of QoL assessments,
Priya Ranganathan +2 more
doaj +1 more source
Determinants of HRQoL: Univariate analysis.
Determinants of HRQoL: Univariate analysis.
Michaël Schwarzinger (193760) +9 more
core +1 more source
Graphical presentations of hypothetical scenarios showing HRQoL outcomes during a trial: (a) a period of improvement followed by worsening at the end of the trial; (b) no change in HRQoL over the course of the trial; (c) initial worsening followed by ...
Julie Bailey (9042581) +9 more
core +1 more source

